A meta-analysis of efficacy and safety of genotype-guided versus standard of care treatment strategies in selecting antiplatelet therapy in patients with acute coronary syndrome.
Salik NazirKeerat R AhujaHafeez Ul Hassan VirkAhmed M ElzanatyTayyab A WaheedKhalid Hamid ChangalKevin WohlfarthVladimir LakhterRobert D GrandeEhab A EltahawyPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
In patients with ACS, genotype-guided initiation of P2Y12 inhibitors was associated with lower odds of MACE and similar bleeding risk in comparison to SCT.